IQVIA Holdings Inc. vs Abbvie Inc.
IQV vs ABBV — side-by-side comparison from reported financials. IQV leads 5, ABBV leads 6 of 11 comparable metrics.
IQVIA Holdings Inc.
IQV · Healthcare
$259.88+0.39%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | IQV | ABBV |
|---|---|---|
| Price | $259.88 | $276.43 |
| Market cap | $42.8B | $488B |
| Revenue (TTM) | $17.0B | $64.4B |
| Revenue growth | +4.2% | +1.8% |
| Net margin | 8.1% | 9.8% |
| Free cash flow | $2.18B | $18.2B |
| Net cash (debt) | ($11.7B) | ($56.2B) |
| 1-year price return | +28.0% | +19.8% |
| P/E | 31.1 | 77.4 |
| P/E vs own history (cheap-side %) | 56% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 22% | 96% |
| Altman Z-score | 1.78 | 2.33 |
| CV checks passed | 8 of 10 | 9 of 10 |
| Employees | 94,000 | 57,000 |
Full résumé-style profiles: IQV CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.